ANAMEKNCT03182491
Mechanisms of Anaphylaxis
StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved at least 2 years 2 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 4 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Oct 1, 2026 to Dec 31, 2028
- Eligibility criteria expanded, about 4 words
- Trial status changed: Unknown → Active, Not Recruiting
- Minor Changed Registry marked status Unknown; last known: Active, Not Recruiting
- Notable Primary and study completion dates pushed to Oct 1, 2026v5
- Notable Primary completion date: Oct 2018 to Dec 2019
- Trial status: Recruiting to Active, Not Recruiting
- Study completion date: Dec 2018 to Jun 2020
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Clarify mechanisms for anaphylaxis and establish biomarkers for this syndrome
Timeframe: 2 days
Arms and interventions
Anaphylaxis
Febrile transfusion reactions
Mild allergic reactions
Healthy controls
Diagnostic tests: Biomarkers (platelet activating factor [PAF], anaphylatoxins) and basophil activation test (BAT)
Sites
1 site in 1 country
- Haukeland University HospitalBergen, Norway